多年来，学术研究与媒体评论对AI应用于新药研发的探讨早已浩如烟海，然则绝大多数仍局限于技术与场景分析，聚焦IT与医药各自或者交叉突破，鲜有深入探讨监管层面的制度设计。尤其作为全球药品监管的标杆机构，FDA对AI技术应用的监管思路，始终是业内亟需填补的 ...

Guangzhou Cloudbutterfly Technology Co., Ltd. Has developed an AI dot-matrix pen that can display exactly what is written on ...

Paul Davidson, director of UKRI’s Smart Plastic Packaging Challenge (SSPP), delivered by Innovate UK, says the stage is set ...